stem cells therapy may be a choice therapy for advanced heart failure patients refractory to
medical therapy, internal cardiovertor with a defibrillator (ICD) recipients, and a previous
history of myocardial infarction and coronary artery revascularization. These patients,
without indication to receive a cardiac resynchronization therapy (CRT), may have a worsening
of heart failure, and symptoms of coronary artery disease. In this study we have evaluated in
consecutive 30 selected patients the amelioration in failing heart NYHA class,
hospitalization rate, echocardiographic left ventricle functionality, and associated to
reduction of angina after a treatment with stem cells intra thoracic infusion.
Phase:
Phase 4
Details
Lead Sponsor:
Second University of Naples University of Campania "Luigi Vanvitelli"